Product/Service Approvals

Abbott Laboratories says FDA unbiased panel votes to approve coronary heart machine

Moderna’s inventory soars after Oppenheimer upgrades to purchase

Ionis, AstraZeneca get FDA approval for uncommon genetic illness therapy

Medtronic will get FDA approval for brand spanking new heart-condition therapy

Bitcoin and ether rally on ETF optimism, sparking hope of a ‘crypto spring’

Eli Lilly will get FDA approval for brand spanking new weight problems drug

Amgen will get FDA approval for its inflammatory ailments therapy Wezlana

Biogen and Eisai launch new Alzheimer’s drug knowledge which will help wider uptake

Pfizer will get FDA inexperienced mild for brand spanking new shot that may streamline youngsters’ vaccinations

Ardelyx wins lengthy battle for FDA approval of kidney-disease remedy